One Equity Partners, the private investment arm of J.P. Morgan Chase & Co., said Monday that it has closed its buy of PeroxyChem from FMC for approximately $200 million. PeroxyChem is a chemistries provider.
PHILADELPHIA–(BUSINESS WIRE)–One Equity Partners, the global private investment arm of J.P. Morgan Chase & Co., announced today the completion of the acquisition of PeroxyChem, formerly FMC Global Peroxygens, a business division of FMC Corporation specializing in peroxygen chemistries. The acquisition includes all sales, manufacturing, and supply chain and R&D capabilities of FMC Global Peroxygens and was valued at approximately $200 million.
This acquisition enables PeroxyChem to extend its market position as a global leader in the manufacturing of hydrogen peroxide, persulfates, peracetic acid and environmental remediation technologies while continuing to provide customized solutions, technical expertise and ongoing support to existing and new customers. PeroxyChem expects no changes to daily operations as a result of the sale.
“PeroxyChem’s strategy is to be fully focused on the production and innovation of high quality peroxygen products and related technologies for a diverse set of industrial and specialty markets,” said Bruce Lerner, PeroxyChem President and CEO. “With a portfolio of high quality products, superb technical expertise, as well as operational excellence and a talented team of employees around the world it is a very exciting way to launch a new company.”
PeroxyChem becomes a part of One Equity Partners’ successful history of building strong, global chemical businesses. One Equity Partners manages capital and commitments of approximately $14 billion. Its portfolio companies in the chemical business sector have included Columbian Chemicals, SudChemie, OCI, Chemlogics, Sonneborn and LBC Tank Terminals.
“One Equity Partners has developed a deep understanding of the international chemical industry and invests only in businesses and management teams we are confident will succeed,” said Tom Kichler, Managing Director of One Equity Partners. “PeroxyChem is already an outstanding manufacturer of peroxygen chemistries for diverse applications and we look forward to helping it grow and strengthen its position as an industry leader.”
PeroxyChem is a global leader in peroxygen and adjacent chemistries with facilities in North America, Europe and Asia. With an unyielding commitment to safety at its core, the company prides itself on exemplary customer service, product quality, reliability and technical service. PeroxyChem manufactures high quality products and innovative applications developed as a result of ingenuity and technical expertise. We supply customized chemistries for electronics, environmental, food and beverage, oil and gas production, pulp, paper and other industrial markets. Visit PeroxyChem.com to learn more.
About One Equity Partners
One Equity Partners is the private investment arm of J.P. Morgan Chase & Co. and has managed approximately $14 billion in commitments and investments solely for the bank since inception. OEP enters into long-term partnerships with companies to create sustainable value through long-term growth driven both organically and inorganically. Founded in 2001, OEP has 35 investment professionals in New York, Chicago, Frankfurt, Hong Kong, Sao Paulo and elsewhere around the globe. Visit www.oneequity.com for more information.
FMC Corporation is a diversified chemical company serving agricultural, industrial, environmental, and consumer markets globally for more than a century with innovative solutions, applications and quality products. In 2013, FMC had annual sales of approximately $3.9 billion. The company employs approximately 5,600 people throughout the world, and operates its businesses in three segments: FMC Agricultural Solutions, FMC Health and Nutrition, and FMC Minerals. For more information, visit www.FMC.com.